ACY-1215

ricolinostat · Acetylon Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACY-1215, covering 2017-04-06 to 2024-08-06. Get the full timeline:

Most recent: Clinical Trial Update: ACY-1215 for Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]